RCE 0.93% 54.0¢ recce pharmaceuticals ltd

Accelerated Approval for RECCE® 327, page-89

  1. 9,938 Posts.
    lightbulb Created with Sketch. 227
    Here is more recent reading for those interested:

    https://www.monash.edu/news/articles/monash-helps-address-superbug-resistance-with-phage-therapy

    http://time.com/5068513/superbugs-are-nearly-impossible-to-fight/

    and by way of balancing the debate:

    https://www.forbes.com/sites/quora/...roblem-of-antibiotic-resistance/#2a3d83e3bf3f

    Besides Phage Technology, there are a good many other more traditional developments being undertaken, as well as other synthetics.

    None of this is to devalue the potential for Recce, perhaps just to try and explain my personal reluctance to jump in yet, and my skepticism of some of the outrageous (and laughable) SP predictions that have been floated. (Although I do like to dream too!)

    Keeping an objective view, without emotion and greed overtaking us, is so very hard.

    I like Recce, and besides the above, there are still serious questions besides Dr Melrose's longevity in control and importantly, no news has yet addressed the potential to upscale production to a commercially viable level - ???

    Plenty of other flags.

    GLTA

    Cabe
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.